Red Havas has merged its health agencies in Europe and the US with individual health comms professionals across the Asia Pacific region to create the single unified brand Red Havas Health, it announced today.
GSK is set to announce US job cuts this week, sales reps are getting the axe in China, and the FDA has rejected Avanir’s inhalable migraine medication.
Loading...
MM+M Transform: The Patient, Provider and Payer Engagement Matrix